Dexcom reports 2025 revenues of $4.66bn yet 2026 outlook lags analyst expectations
Dexcom has achieved revenues of $4.66bn in 2025 and beat analysts’ consensus for Q4 performance amid a strong demand for …
Post
-
-
Novocure’s stock rises 37% on FDA clearance of pancreatic cancer treatment device
The US Food & Drug Administration (FDA) has cleared Novocure’s Optune Pax device for locally advanced pancreatic cancer treatment, representing …
-
OncoRes Medical raises funding to advance Elora clinical development
Australia-based OncoRes Medical has completed A$27m($19.1m) private funding round to support the clinical development and regulatory advancement of its quantitative …
-
Philips unveils new InkSpace Snuggle coil for paediatric imaging
Philips has introduced the InkSpace Imaging Snuggle flexible paediatric body array coil, designed for use with its 3.0T magnetic resonance …
-
Encora Therapeutics gains FDA clearance for essential tremor device
The US Food and Drug Administration (FDA) has cleared Encora Therapeutics’ neurostimulation wearable for essential tremor (ET) management. The Massachusetts-based company’s …
-
Abbott initiates UK pilot of Volt PFA system
Abbott has initiated a trial of its Volt pulsed-field ablation (PFA) system at 15 UK National Health Service (NHS) hospitals …
-
Neurent secures $74m to expand NEUROMARK commercial activities
Neurent Medical has closed an oversubscribed Series C financing round, raising €62.5m ($74m) to expand commercial activities for the NEUROMARK …
-
Natus Sensory acquires medical technology company TheraB Medical
Natus Sensory has purchased TheraB Medical, a US-based company specialising in neonatal wearable phototherapy devices. The acquisition aims to extend access …
-
Mira announces hormone data integration with ŌURA’s smart ring
Femtech company Mira is collaborating with ŌURA, allowing users of the Finnish company’s Oura smart ring to access lab-grade hormone …
-
Edwards reports strong 2025 despite Q4 EPS miss
Edwards Lifesciences has reported revenue over $6bn in full year 2025, predominantly driven by strong demand for its transcatheter aortic …
-
ZOLL achieves EU MDR approval for Zenix device
Asahi Kasei’s ZOLL has received approval for its Zenix monitor/defibrillator under the European Union Medical Device Regulation 2017/745 (EU MDR). The …
-
Merck and Calla Lily partner to advance Callavid platform
Merck KGaA (Merck) and Calla Lily Clinical Care have announced a strategic partnership to advance Callavid, an intravaginal drug delivery …
-
Zimmer Biomet reports 2025 revenue growth yet tempers 2026 outlook
Zimmer Biomet has achieved revenue of $8.23bn in full year 2025 off the back of continued strong demand across its …
-
UK government champions healthtech through new NHS access programme
The UK government has set out to improve access to healthcare technology within the National Health Service (NHS) through the …
-
BD shares fall by 3% after lowering FY26 profit outlook
Becton Dickinson and Company (BD) has trimmed its fiscal year 2026 (FY26) profit outlook to account for the spin-off of …
